Lorenz Risch
SARS-CoV-2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study.
Dörr T, Güsewell S, Cusini A, Brucher A, Goppel S, Grässli F, Betschon E, Möller J, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, Risch L, von Kietzell M, Schlegel M, Kuster S, Kahlert C, Kohler P, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group. SARS-CoV-2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study. Influenza Other Respir Viruses 2024; 18:e13333.
Jun 1, 2024SARS-CoV-2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study.
Jun 1, 2024Influenza Other Respir Viruses 2024; 18:e13333
Dörr Tamara, Güsewell Sabine, Cusini Alexia, Brucher Angela, Goppel Stephan, Grässli Fabian, Betschon Elsbeth, Möller J. Carsten, Ortner Manuela, Ruetti Markus, Stocker Reto, Vuichard-Gysin Danielle, Besold Ulrike, Risch Lorenz, von Kietzell Matthias, Schlegel Matthias, Kuster Stefan, Kahlert Christian, Kohler Philipp, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group
Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Kahlert C, Strahm C, Güsewell S, Cusini A, Brucher A, Goppel S, Möller E, Möller J, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kuster S, Kohler P, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin Infect Dis 2023; 77:194-202.
Jul 26, 2023Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Jul 26, 2023Clin Infect Dis 2023; 77:194-202
Kahlert Christian, Strahm Carol, Güsewell Sabine, Cusini Alexia, Brucher Angela, Goppel Stephan, Möller Elisabeth, Möller J. Carsten, Ortner Manuela, Ruetti Markus, Stocker Reto, Vuichard-Gysin Danielle, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kuster Stefan, Kohler Philipp, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Kohler P, Babouee Flury B, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Ortner M, Rieder P, Ruetti M, Schmid H, Stocker R, Vuichard-Gysin D, Speer O, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert C, Kuster S, SURPRISE Study Group. Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study). Influenza Other Respir Viruses 2023; 17:e13167.
Jun 19, 2023Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Jun 19, 2023Influenza Other Respir Viruses 2023; 17:e13167
Kohler Philipp, Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio B, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J. Carsten, Ortner Manuela, Rieder Philippe, Ruetti Markus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Speer Oliver, Wiggli Benedikt, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kahlert Christian, Kuster Stefan, SURPRISE Study Group
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali O, Pop O, Risch L, Brugger S, Velic A, Bomze D, Kohler P, Vernazza P, Albrich W, Kahlert C, Abdou M, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat S, Ruetalo N, Buehler P, Scheier T, Jochum W, Kern L, Henz S, Schneider T, Kuster G, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy K, Spengler W, Brutsche M, Macek B, Twerenbold R, Penninger J, Matter M, Flatz L, Jochum A. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19. Am J Respir Crit Care Med 2023; 207:38-49.
Jan 1, 2023Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Jan 1, 2023Am J Respir Crit Care Med 2023; 207:38-49
Sinnberg Tobias, Lichtensteiger Christa, Ali Omar Hasan, Pop Oltin T, Risch Lorenz, Brugger Silvio D, Velic Ana, Bomze David, Kohler Philipp, Vernazza Pietro, Albrich Werner, Kahlert Christian, Abdou Marie-Therese, Wyss Nina, Hofmeister Kathrin, Niessner Heike, Zinner Carl, Gilardi Mara, Tzankov Alexandar, Röcken Martin, Dulovic Alex, Shambat Srikanth Mairpady, Ruetalo Natalia, Buehler Philipp K, Scheier Thomas C, Jochum Wolfram, Kern Lukas, Henz Samuel, Schneider Tino, Kuster Gabriela M, Lampart Maurin, Siegemund Martin, Bingisser Roland, Schindler Michael, Schneiderhan-Marra Nicole, Kalbacher Hubert, McCoy Kathy D, Spengler Werner, Brutsche Martin H, Macek Boris, Twerenbold Raphael, Penninger Josef M, Matter Matthias S, Flatz Lukas, Jochum Ann-Kristin
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Rütti M, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Kuster S, Kahlert C, Kohler P, SURPRISE Study Group. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. PLoS Med 2022; 19:e1004125.
Nov 7, 2022Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Nov 7, 2022PLoS Med 2022; 19:e1004125
Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Rütti Markus, Schmid Hans-Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Kuster Stefan, Kahlert Christian, Kohler Philipp, SURPRISE Study Group
Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.
Strahm C, Seneghini M, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Ruetti M, Rutz R, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Schmid D, Vernazza P, Kahlert C, Kohler P. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort. Clin Infect Dis 2022; 75:e1011-e1019-9.
Aug 24, 2022Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.
Aug 24, 2022Clin Infect Dis 2022; 75:e1011-e1019-9
Strahm Carol, Seneghini Marco, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Ruetti Markus, Rutz Remus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, Kuster Stefan, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Schmid Dagmar, Vernazza Pietro, Kahlert Christian, Kohler Philipp
Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort
Sumer J, Schlegel M, Vernazza P, Seneghini M, Nigg S, Risch L, Mueller N, Kahlert C, Flury D, Kohler P. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort. Int J Public Health 2022; 67:1604147.
Feb 16, 2022Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort
Feb 16, 2022Int J Public Health 2022; 67:1604147
Sumer Johannes, Schlegel Matthias, Vernazza Pietro, Seneghini Marco, Nigg Susanne, Risch Lorenz, Mueller Nicolas J, Kahlert Christian, Flury Domenica, Kohler Philipp
Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
Haller S, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kahlert C, Stocker R, Rütti M, Güsewell S, Egger T, Scanferla G, Thoma R, Leal-Neto O, Flury D, Brucher A, Lemmenmeier E, Möller J, Rieder P, Kohler P. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort. Antimicrob Resist Infect Control 2022; 11:27.
Feb 5, 2022Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
Feb 5, 2022Antimicrob Resist Infect Control 2022; 11:27
Haller Sabine, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, Kuster Stefan, McGeer Allison, Risch Lorenz, Schlegel Matthias, Friedl Andree, Vernazza Pietro, Kahlert Christian, Stocker Reto, Rütti Markus, Güsewell Sabine, Egger Thomas, Scanferla Giulia, Thoma Reto, Leal-Neto Onicio B, Flury Domenica, Brucher Angela, Lemmenmeier Eva, Möller J Carsten, Rieder Philip, Kohler Philipp
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
Kohler P, Jonsdottir H, Risch L, Vernazza P, Ackermann-Gäumann R, Kahlert C. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study. Sci Rep 2021; 11:24198.
Dec 17, 2021No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
Dec 17, 2021Sci Rep 2021; 11:24198
Kohler Philipp, Jonsdottir Hulda R, Risch Lorenz, Vernazza Pietro, Ackermann-Gäumann Rahel, Kahlert Christian
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde M, Niederer R, Wagner N, Diem S, Berner F, Hasan Ali O, Hillmann D, Bergamin I, Jörger M, Risch M, Niederhauser C, Lenz T, Früh M, Risch L, Semela D, Flatz L. Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. J Cancer Res Clin Oncol 2021; 148:647-656.
Dec 7, 2021Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Dec 7, 2021J Cancer Res Clin Oncol 2021; 148:647-656
Purde Mette-Triin, Niederer Rebekka, Wagner Nikolaus, Diem Stefan, Berner Fiamma, Hasan Ali Omar, Hillmann Dorothea, Bergamin Irina, Jörger Markus, Risch Martin, Niederhauser Christoph, Lenz Tobias L, Früh Martin, Risch Lorenz, Semela David, Flatz Lukas
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
Nov 2, 2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Nov 2, 2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner, Kohler Philipp, Kahlert Christian, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study
Kohler P, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Vuichard-Gysin D, Stocker R, Ruetti M, Güsewell S, Seneghini M, Egger T, Leal O, Brucher A, Lemmenmeier E, Möller J, Rieder P, Kahlert C. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study. BMC Med 2021; 19:270.
Oct 14, 2021Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study
Oct 14, 2021BMC Med 2021; 19:270
Kohler Philipp, Wiggli Benedikt, Besold Ulrike, Kuster Stefan, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro, Vuichard-Gysin Danielle, Stocker Reto, Ruetti Markus, Güsewell Sabine, Seneghini Marco, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Möller J Carsten, Rieder Philip, Kahlert Christian
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study
Kahlert C, Albrich W, Babouee Flury B, Besold U, Fehr J, Kuster S, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Wiggli B, Vuichard-Gysin D, Stocker R, Persi R, Güsewell S, Egger T, Leal-Neto O, Sumer J, Flury D, Brucher A, Lemmenmeier E, Möller J, Rieder P, Kohler P. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Clin Microbiol Infect 2021; 27:1336-1344.
May 19, 2021Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study
May 19, 2021Clin Microbiol Infect 2021; 27:1336-1344
Kahlert Christian, Albrich Werner, Babouee Flury Baharak, Besold Ulrike, Fehr Jan, Kuster Stefan, McGeer Allison, Risch Lorenz, Schlegel Matthias, Friedl Andree, Vernazza Pietro, Wiggli Benedikt, Vuichard-Gysin Danielle, Stocker Reto, Persi Raphael, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio B, Sumer Johannes, Flury Domenica, Brucher Angela, Lemmenmeier Eva, Möller J Carsten, Rieder Philip, Kohler Philipp
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Weber M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Bodmer T, Egli K, Risch M, Thiel S, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Kahlert C. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
Jan 6, 2021Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Jan 6, 2021Dis Markers 2021; 2021:8810196
Weber Myriam C, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Heer Sonja, Renz Harald, Paprotny Matthias, Kohler Philipp, Vernazza Pietro, Risch Lorenz, Bodmer Thomas, Egli Konrad, Risch Martin, Thiel Sarah L, Grossmann Kirsten, Nigg Susanne, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Kahlert Christian
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
Jan 2, 2021Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Jan 2, 2021Clin Infect Dis 2021; 73:e2869-e2874
Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas
The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
Vernazza P, Risch L, Lange K, Esson C, Hauser C, Aebi-Popp K, Stoffel M, Dost F, Ritzler M, Rasi M, Schmidt A. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women. Swiss Med Wkly 2020; 150:w20393.
Dec 31, 2020The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
Dec 31, 2020Swiss Med Wkly 2020; 150:w20393
Vernazza Pietro, Risch Lorenz, Lange Katharina, Esson Cate, Hauser Christoph V, Aebi-Popp Karoline, Stoffel Milena, Dost Ferah, Ritzler Michael, Rasi Manuela, Schmidt Axel Jeremias
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Schaffner A, Bodmer T, Imperiali M, Renz H, Kohler P, Vernazza P, Kahlert C, Twerenbold R, Paprotny M, Conen D, Bigler S, Hillmann D, Lung T, Risch L, Aeschbacher S, Risch C, Weber M, Thiel S, Jüngert K, Pichler M, Grossmann K, Wohlwend N, Risch M. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. J Clin Med 2020; 9
Dec 9, 2020Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Dec 9, 2020J Clin Med 2020; 9
Schaffner Anna, Bodmer Thomas, Imperiali Mauro, Renz Harald, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Twerenbold Raphael, Paprotny Matthias, Conen David, Bigler Susanna, Hillmann Dorothea, Lung Thomas, Risch Lorenz, Aeschbacher Stefanie, Risch Corina, Weber Myriam C, Thiel Sarah L, Jüngert Katharina, Pichler Michael, Grossmann Kirsten, Wohlwend Nadia, Risch Martin
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Risch M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Renz H, Kohler P, Vernazza P, Kahlert C, Paprotny M, Bodmer T, Egli K, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Risch L. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int 2020; 2020:9878453.
Nov 16, 2020Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Nov 16, 2020Biomed Res Int 2020; 2020:9878453
Risch Martin, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Renz Harald, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Paprotny Matthias, Bodmer Thomas, Egli Konrad, Weber Myriam, Thiel Sarah, Grossmann Kirsten, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Risch Lorenz
Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study
Thiel S, Copeland S, Karajan T, Cusini A, Fleisch F, Kahlert C, Vernazza P, Risch M, Ritzler M, Hillmann D, Lung T, Wohlwend N, Risch L, Weber M, Paprotny M. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study. Swiss Med Wkly 2020; 150:w20361.
Oct 16, 2020Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study
Oct 16, 2020Swiss Med Wkly 2020; 150:w20361
Thiel Sarah Lucia, Copeland Sandra, Karajan Tomas V, Cusini Alexia, Fleisch Felix, Kahlert Christian, Vernazza Pietro, Risch Martin, Ritzler Michael, Hillmann Dorothea, Lung Thomas, Wohlwend Nadia, Risch Lorenz, Weber Myriam Carol, Paprotny Matthias
Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
Kohler P, Schlegel M, Risch L, Kuster S, McGeer A, Babouee Flury B, Albrich W, Notter J, Leal-Neto O, Güsewell S, Flury D, Sumer J, Kahlert C, Vernazza P. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study. Infect Control Hosp Epidemiol 2020; 42:604-608.
Oct 8, 2020Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
Oct 8, 2020Infect Control Hosp Epidemiol 2020; 42:604-608
Kohler Philipp, Schlegel Matthias, Risch Lorenz, Kuster Stefan, McGeer Allison, Babouee Flury Baharak, Albrich Werner, Notter Julia, Leal-Neto Onicio B, Güsewell Sabine, Flury Domenica, Sumer Johannes, Kahlert Christian, Vernazza Pietro